Actinium Pharmaceuticals Inc., a biopharmaceutical company developing immunotherapeutics for advanced cancers, has appointed Felix Garzon senior vice president, head of clinical development. Dr. Garzon brings with him 28 years of pharmaceutical and biotechnology experience in increasingly senior roles, most recently at Eisai and Bristol-Myers Squibb, having worked on both later and earlier stages of drug development.  “I am very excited to join the Actinium organization,” said Dr....